Drug Combo Shows Promise Against Advanced Head and Neck Cancer
MONDAY, April 3, 2023 (HealthDay News) — An experimental targeted drug could provide a fresh chance for people with recurring head and neck cancer that has grown resistant to other treatments, a new clinical trial says.Ficlatuzumab used in combinatio…
Learn MoreMonthly Injections Might Lower Bleeding in People With Hemophilia
FRIDAY, March 31, 2023 (HealthDay News) — An experimental injectable drug appears effective in reducing bleeds in patients with hemophilia A and B, according to a pair of new clinical trials.Two-thirds of people with treatment-resistant hemophilia wh…
Learn MoreDoctors Convert Veins Into Arteries to Spare Patients Amputations
THURSDAY, March 30, 2023 (HealthDay News) — Cynthia Elford had recently lost her left leg to type 1 diabetes, after a sunburned big toe turned nearly black and forced an amputation.Now, Elford was being told the same thing was happening in her right …
Learn MoreNew Drug Could Be Treatment Option for People With Eczema
MONDAY, March 20, 2023 (HealthDay News) — Patients could soon have access to a new injectable drug to treat atopic dermatitis, the most common form of eczema.The drug, lebrikizumab, proved effective in teenagers and adults in two clinical trials just…
Learn MoreRace, Ethnicity Reporting in Pediatric Clinical Trials Has Improved
TUESDAY, March 14, 2023 (HealthDay News) — Race and ethnicity reporting has improved significantly in pediatric clinical trials, but there is still underrepresentation of certain racial and ethnic groups, according to a study published online March 1…
Learn MoreACC: Sotatercept Boosts Exercise Capacity With Pulmonary Arterial Hypertension
FRIDAY, March 10, 2023 (HealthDay News) — Sotatercept is associated with a greater improvement in exercise capacity than placebo among patients with pulmonary arterial hypertension (PAH) receiving stable background therapy, according to a study publi…
Learn MoreThough Often Prescribed, Diuretic Pills May Not Prevent Kidney Stones
MONDAY, March 6, 2023 (HealthDay News) — A new study is raising questions about the effectiveness of medications long used to prevent painful kidney stones, but experts say there’s no reason for patients to toss their prescriptions out at this point….
Learn MoreUn nuevo medicamento inyectado podría prevenir la COVID grave
JUEVES, 9 de febrero de 2023 (HealthDay News) — Una sola inyección de un medicamento biológico experimental podría reducir a la mitad el riesgo de hospitalización por una infección con la COVID-19, muestran los resultados de un nuevo ensayo clínico.E…
Learn More‘Neuroprotectant’ Drug Could Boost Outcomes After a Stroke
THURSDAY, Feb. 9, 2023 (HealthDay News) — Using a “neuroprotectant” drug alongside the standard surgical removal of a clot may slash the risk of death and disability following a stroke, a new study finds.The new medication, called ApTOLL, shields bra…
Learn MoreNew Injected Drug May Prevent Severe COVID
THURSDAY, Feb. 9, 2023 (HealthDay News) — A single injection of an experimental biologic drug may cut in half your risk of hospitalization from COVID-19 infection, new clinical trial results show.Pegylated lambda interferon (PEG-lambda) proved effect…
Learn More